Novo Nordisk A/S (NVO) News Today $74.03 -0.32 (-0.42%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$73.99 -0.03 (-0.04%) As of 09:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period McDonald’s Is Down, But Long-Term Investors Can Still Take a Bite (NVO)Analysts are downgrading McDonald's and the stock may have further to fall, but as a long-term opportunity, it may be getting to a point of offering real valueJune 20 at 8:04 AM | marketbeat.comAutumn Glory Partners LLC Acquires 19,922 Shares of Novo Nordisk A/S (NYSE:NVO)Autumn Glory Partners LLC grew its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 122.9% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 36,130 shares of the company's stock after buying an additional 19,922 shareJune 19 at 7:49 AM | marketbeat.com4,172 Shares in Novo Nordisk A/S (NYSE:NVO) Acquired by Wolf Group Capital AdvisorsWolf Group Capital Advisors acquired a new stake in Novo Nordisk A/S (NYSE:NVO - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 4,172 shares of the company's stock, valued at approximatelyJune 19 at 4:50 AM | marketbeat.comInscription Capital LLC Purchases New Position in Novo Nordisk A/S (NYSE:NVO)Inscription Capital LLC acquired a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 4,831 shares of the company's stock, valued at approximately $335,000. A number of other institutionJune 19 at 4:21 AM | marketbeat.comUS judge upholds FDA’s removal of Ozempic, Wegovy from drug shortage listJune 18 at 2:56 PM | investing.comNovo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?June 18 at 2:56 PM | msn.comU.S. judge upholds FDA's removal of Ozempic, Wegovy from drug shortage listJune 18 at 12:03 PM | reuters.comNovo Nordisk Reclaims Top Spot in Europe by Market ValueJune 18 at 2:33 AM | msn.comNovo Nordisk Is Teaming Up With Nvidia. Should You Buy NVO Stock Now?June 18 at 2:33 AM | msn.comNovo Nordisk A/S (NYSE:NVO) Shares Down 2.4% - Here's What HappenedNovo Nordisk A/S (NYSE:NVO) Trading Down 2.4% - Time to Sell?June 17 at 2:36 PM | marketbeat.comNovo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small feeJune 17 at 7:55 AM | msn.comBfsg LLC Raises Stock Holdings in Novo Nordisk A/S (NYSE:NVO)Bfsg LLC increased its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 12.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 115,507 shares of the company's stock after buying an additional 12,515 shares during the period. NovoJune 17 at 6:34 AM | marketbeat.comJLB & Associates Inc. Raises Stake in Novo Nordisk A/S (NYSE:NVO)JLB & Associates Inc. boosted its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 2.3% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 219,239 shares of the company's stock after buying an additional 4,874 shares during the period. Novo NordiskJune 17 at 5:28 AM | marketbeat.comGrimes & Company Inc. Grows Stock Position in Novo Nordisk A/S (NYSE:NVO)Grimes & Company Inc. lifted its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 3.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 106,953 shares of the company's stock after purchasing an additional 3,273June 17 at 4:53 AM | marketbeat.comQRG Capital Management Inc. Decreases Stock Position in Novo Nordisk A/S (NYSE:NVO)QRG Capital Management Inc. cut its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 8.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 231,236 shares of the company's stock after selling 20,600 shares dJune 17 at 4:44 AM | marketbeat.comNovo Nordisk: An Elite Company That Prints MoneyJune 16, 2025 | seekingalpha.comWhy Novo Nordisk Stock Sank by Nearly 4% TodayJune 16, 2025 | fool.comNovo Nordisk A/S (NYSE:NVO) Shares Down 3.1% - Here's What HappenedNovo Nordisk A/S (NYSE:NVO) Stock Price Down 3.1% - What's Next?June 16, 2025 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Gap Down - What's Next?Novo Nordisk A/S (NYSE:NVO) Shares Gap Down - Should You Sell?June 16, 2025 | marketbeat.comOzempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard SaynorJune 16, 2025 | benzinga.comFNY Investment Advisers LLC Makes New $623,000 Investment in Novo Nordisk A/S (NYSE:NVO)FNY Investment Advisers LLC purchased a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 8,972 shares of the company's stock, valued at approximately $6June 16, 2025 | marketbeat.comShikiar Asset Management Inc. Sells 90,399 Shares of Novo Nordisk A/S (NYSE:NVO)Shikiar Asset Management Inc. cut its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 94.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,760 shares of the company's stock after selling 90,399June 16, 2025 | marketbeat.comSolstein Capital LLC Trims Stake in Novo Nordisk A/S (NYSE:NVO)Solstein Capital LLC reduced its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 26.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,277 shares of the company's stock after selJune 16, 2025 | marketbeat.comBrown Miller Wealth Management LLC Has $791,000 Position in Novo Nordisk A/S (NYSE:NVO)Brown Miller Wealth Management LLC raised its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 38.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,394 shares of the company's stock after acquiJune 16, 2025 | marketbeat.comThe story of how Novo Nordisk will lose billions because it didn't pay a couple of hundred dollarsJune 16, 2025 | marketwatch.comNovo Nordisk: The Strength To Withstand ChallengesJune 16, 2025 | seekingalpha.comNovo Nordisk A/S (NYSE:NVO) Shares Acquired by North Star Investment Management Corp.North Star Investment Management Corp. increased its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 18.2% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,742 shares of the company's sJune 16, 2025 | marketbeat.comJim Cramer on Novo Nordisk: “We’re Not Novo People”June 15, 2025 | msn.comBernstein Keeps a Hold on Novo Nordisk (NVO), Sets a DKK620 Price TargetJune 15, 2025 | msn.comRitholtz Wealth Management Trims Stock Position in Novo Nordisk A/S (NYSE:NVO)Ritholtz Wealth Management reduced its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 13.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 104,309 shares of the company's stock after selliJune 15, 2025 | marketbeat.comWealthcare Advisory Partners LLC Sells 21,139 Shares of Novo Nordisk A/S (NYSE:NVO)Wealthcare Advisory Partners LLC decreased its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 83.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,286 shares of the company's stoJune 15, 2025 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Yousif Capital Management LLCYousif Capital Management LLC trimmed its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 31.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,296 shares of the company's stock after selling 16,500 shares dJune 15, 2025 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Upgraded to "Buy" at Wall Street ZenJune 15, 2025 | americanbankingnews.comDover Advisors LLC Purchases Shares of 7,154 Novo Nordisk A/S (NYSE:NVO)Dover Advisors LLC bought a new position in Novo Nordisk A/S (NYSE:NVO - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 7,154 shares of the company's stock, valued at approJune 14, 2025 | marketbeat.comAzzad Asset Management Inc. ADV Buys New Shares in Novo Nordisk A/S (NYSE:NVO)Azzad Asset Management Inc. ADV bought a new stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 53,530 shares of the company's stock, valued at approJune 14, 2025 | marketbeat.comElevation Point Wealth Partners LLC Grows Stock Holdings in Novo Nordisk A/S (NYSE:NVO)Elevation Point Wealth Partners LLC increased its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 23.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 41,509 shares of thJune 14, 2025 | marketbeat.comStanley Laman Group Ltd. Buys New Shares in Novo Nordisk A/S (NYSE:NVO)Stanley Laman Group Ltd. bought a new stake in Novo Nordisk A/S (NYSE:NVO - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 5,618 shares of the company's stock, valued at approximately $390,000. SJune 14, 2025 | marketbeat.comRhumbline Advisers Grows Position in Novo Nordisk A/S (NYSE:NVO)Rhumbline Advisers raised its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 10.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 63,539 shares of the company's stock after acquiring an additional 5,898 shares during the period.June 14, 2025 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Upgraded at Wall Street ZenWall Street Zen upgraded Novo Nordisk A/S from a "hold" rating to a "buy" rating in a report on Saturday.June 14, 2025 | marketbeat.comNovo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail TalkingJune 13, 2025 | msn.comNovo Nordisk A/S (NYSE:NVO) Trading Down 1.3% - Time to Sell?Novo Nordisk A/S (NYSE:NVO) Shares Down 1.3% - Time to Sell?June 13, 2025 | marketbeat.comNovo Nordisk Is Europe's Most Valuable Company—Again. Eli Lilly, Watch Out.June 13, 2025 | barrons.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Bar Harbor Wealth ManagementBar Harbor Wealth Management lessened its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 23.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 58,817 shares of the company's stock after sellinJune 13, 2025 | marketbeat.comSmithbridge Asset Management Inc. DE Makes New Investment in Novo Nordisk A/S (NYSE:NVO)Smithbridge Asset Management Inc. DE purchased a new position in Novo Nordisk A/S (NYSE:NVO - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 88,531 shares of the company's stock, valued at approximatJune 13, 2025 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Bought by Union Bancaire Privee UBP SAUnion Bancaire Privee UBP SA lifted its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 291.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 34,576 shares of the company's stock after buying an additionalJune 13, 2025 | marketbeat.comSimon Quick Advisors LLC Purchases 4,241 Shares of Novo Nordisk A/S (NYSE:NVO)Simon Quick Advisors LLC boosted its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 63.5% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,918 shares of the company's stock after acquiring an addiJune 13, 2025 | marketbeat.comNovo Nordisk regains crown as Europe's most valuable companyJune 13, 2025 | reuters.comWhy Novo Nordisk Stock Pumped Higher on ThursdayJune 12, 2025 | fool.comNovo Nordisk A/S (NYSE:NVO) Trading 2.7% Higher - Still a Buy?Novo Nordisk A/S (NYSE:NVO) Shares Up 2.7% - What's Next?June 12, 2025 | marketbeat.comNovo Nordisk plans to start late-stage trials of obesity drug amycretin next yearJune 12, 2025 | investing.com Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼1.070.68▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼4444▲NVO Articles Average Week Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novartis News Today AstraZeneca News Today Sanofi News Today GSK News Today Takeda Pharmaceutical News Today argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredWar-Proof Power Why This "Weird" Government Land Auction Was No Ordinary Sale When 218,000 acres of land... smack in the m...Stansberry Research | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVO Stock Free NVO Stock Alerts